#Dermatology #Psoriasis #MedicalAffairs #Immunology #DrugDevelopment #MSL #Biologics #ClinicalTrials To view or add a comment, sign in BIG NEWS FDA approves Merck and Co Inc LIPFENDRA (enlicitide), the first oral PCSK9 inhibitor to match injectable-level cholesterol lowering Merck won FDA approval for LIPFENDRA (enlicitide), a once-daily 20mg tablet, as an adjunct to diet and exercise to lower LDL-C in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH)
Beyond diet and exercise, dont underestimate the importance of staying hydrated, managing stress levels, and getting enough quality sleep all of which play a role in maintaining progress
This highlights the importance of ensuring sufficient B12 levels to support the overall health and function of the intestines
What This Means for the Future of Medical Weight Loss The development of retatrutide reflects a broader shift toward multi-pathway treatments that address obesity as a complex metabolic condition rather than a single-mechanism problem
Sie knnen sowohl morgens als auch abends in Ihre Hautpflegeroutine integriert werden